Prevalence of UDP-glucuronosyltransferase polymorphisms (UGT1A6*2, 1A7*12, 1A8*3, 1A9*3, 2B7*2, and 2B15*2) in a Saudi population

被引:2
|
作者
Alkharfy, Khalid M. [1 ]
Jan, Basit L. [1 ]
Afzal, Sibtain [2 ,3 ]
Al-Jenoobi, Fahad I. [4 ]
Al-Mohizea, Abdullah M. [4 ]
Al-Muhsen, Saleh [2 ,3 ]
Halwani, Rabih [2 ,3 ]
Parvez, Mohammad K. [5 ]
Al-Dosari, Mohammed S. [5 ]
机构
[1] King Saud Univ, Dept Clin Pharm, Riyadh, Saudi Arabia
[2] King Saud Univ, Coll Med, Dept Pediat, Asthma Res Chair, Riyadh, Saudi Arabia
[3] King Saud Univ, Coll Med, Prince Naif Ctr Immunol Res, Riyadh, Saudi Arabia
[4] King Saud Univ, Dept Pharmaceut, Riyadh, Saudi Arabia
[5] King Saud Univ, Dept Pharmacognosy, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia
关键词
Glucuronidation; UDP-glucuronosyltransferase; UGT1A; UGT2B; Saudi gene polymorphism; CANCER-PATIENTS; HUMAN LIVER; MORPHINE GLUCURONIDATION; IRINOTECAN TOXICITY; ORAL MORPHINE; HUMAN COLON; 2B7; UGT2B7; IDENTIFICATION; METABOLISM; FLAVOPIRIDOL;
D O I
10.1016/j.jsps.2016.05.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Glucuronidation is an important phase II pathway responsible for many endogenous substances and drug metabolism. The present work evaluated allele frequencies of certain UDP-glucuronosyl-transferases (UGT 1A6*2, A7*12, A8*3, A9*3, 2B7*2, and 2B15*2) in Saudi Arabians that could provide essential ethnic information. Blood samples from 192 healthy unrelated Saudi males of various geographic regions were collected. Genomic DNA was isolated and genotyping of various UGTs was carried out using polymerase chain reaction (PCR) followed by direct sequencing. For UGT1A6*2 A/G genotype, the most common variant was the homozygous repeat (AA) and the most common allele was (A) with a frequency of 46.5% and 67.3%, respectively. Similarly, the most common variant for UGT1A7*12 T/C genotype was the heterozygous repeat (TC) with a frequency of 78.7% while the mutant allele (C) was present in 60.6% of the study population. Both UGT1A8*3 (G/A) and UGT1A9*3 (T/C) showed only a wild homozygous pattern in all screened subjects. For UGT2B7*2, the heterozygous repeat (TC) was found with a frequency of 57.3% and the alleles (A) showed a frequency of 50.8%. In contrast, for UGT2B15*2 (G253T), the heterozygous repeat (TG) presented 62.3% of the subjects where the most common allele (G) was with a frequency of 66.2%. In conclusion, our data indicate that Saudis harbor some important UGT mutations known to affect enzyme activity. Additional studies are therefore, warranted to assess the clinical implications of these gene polymorphisms in this ethnic group. (C) 2016 The Authors.
引用
收藏
页码:224 / 230
页数:7
相关论文
共 50 条
  • [1] Arbidol exhibits strong inhibition towards UDP-glucuronosyltransferase (UGT) 1A9 and 2B7
    Liu, Xin
    Huang, Ting
    Chen, Jian-Xing
    Zeng, Jia
    Fan, Xu-Ran
    Zhu, Xu
    Vu, Zhen-Wen
    Sun, Xiao-Yu
    Hong, Mo
    Sun, Hong-Zhi
    PHARMAZIE, 2013, 68 (12): : 945 - 950
  • [2] The function of uterine UDP-glucuronosyltransferase 1A8 (UGT1A8) and UDP-glucuronosyltransferase 2B7 (UGT2B7) is involved in endometrial cancer based on estrogen metabolism regulation
    Zhao, Feng
    Wang, Xi
    Wang, Yan
    Zhang, Jingbo
    Lai, Ran
    Zhang, Bei
    Zhou, Xueyan
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2020, 19 (03): : 403 - 412
  • [3] The function of uterine UDP-glucuronosyltransferase 1A8 (UGT1A8) and UDP-glucuronosyltransferase 2B7 (UGT2B7) is involved in endometrial cancer based on estrogen metabolism regulation
    Feng Zhao
    Xi Wang
    Yan Wang
    Jingbo Zhang
    Ran Lai
    Bei Zhang
    Xueyan Zhou
    Hormones, 2020, 19 : 403 - 412
  • [4] Heterodimerization of Human UDP-Glucuronosyltransferase 1A9 and UDP-Glucuronosyltransferase 2B7 Alters Their Glucuronidation Activities
    Xue, Jia
    Yin, Jiayi
    Nie, Jing
    Jiang, Huidi
    Zhang, Haitao
    Zeng, Su
    DRUG METABOLISM AND DISPOSITION, 2023, 51 (11) : 1499 - 1507
  • [5] The effect of bovine serum albumin on UDP-glucuronosyltransferase (UGT) 1A9 and 2B7 inhibitory potency
    Lapham, Kimberly
    Novak, Jonathan
    Niosi, Mark
    Leung, Louis Y.
    Goosen, Theunis C.
    DRUG METABOLISM REVIEWS, 2016, 48 : 90 - 90
  • [6] Inhibition Kinetic Determination of Ginsenoside Rh2 Towards UDP-Glucuronosyltransferase (UGT) 2B7 and 2B15
    Sun, Fu-Guang
    Gao, Lei
    Song, Bin
    Su, Wei-Na
    Zhang, Ji-Ling
    Tan, Hong-Wu
    LATIN AMERICAN JOURNAL OF PHARMACY, 2014, 33 (04): : 688 - 690
  • [7] Interactions Between Human UDP-Glucuronosyltransferase (UGT) 2B7 and UGT1A Enzymes
    Fujiwara, Ryoichi
    Nakajima, Miki
    Oda, Shingo
    Yamanaka, Hiroyuki
    Ikushiro, Shin-Ichi
    Sakaki, Toshiyuki
    Yokoi, Tsuyoshi
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (01) : 442 - 454
  • [8] Genetic polymorphisms of UDP-glucuronosyltransferases in a healthy Korean population: UGT1A1, 1A6, 2B4, 2B7 and 2B15 subfamilies.
    Yim, D
    Yoon, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P41 - P41
  • [9] Characterizing the effect of UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A9 genetic polymorphisms on enantioselective glucuronidation of flurbiprofen
    Wang, Haina
    Yuan, Lingmin
    Zeng, Su
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (11) : 1757 - 1763
  • [10] EFFECT OF UDP-GLUCURONOSYLTRANSFERASE 1A3, 1A9 AND 2B7 GENETIC POLYMORPHISMS ON 20-HETE GLUCURONIDATION IN HUMAN LIVER TISSUES
    Jarrar, Y. B.
    Oh, K. S.
    Cha, E. Y.
    Kim, Y. R.
    Kim, Y. W.
    Kim, D. H.
    Lee, S. J.
    Shin, J. G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S30 - S31